Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US Drug Approvals Might Skip Second Trial, Rely More On Clinical Pharmacology

This article was originally published in SRA

Executive Summary

The US Food and Drug Administration is working to provide more clarity on when clinical pharmacology data can serve as the confirmatory evidence needed to approve a drug on the basis of a single pivotal trial.